6,546 followers
New research: The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China: Background The KEYNOTE-048 and KEYNOTE-040 study have… https://t.co/wvI